Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20161
Schematic representation of dsRNA- and virus-induced beta cell apoptosis.
Published 2011“…<b>1</b>) Cytoplasmic dsRNA activates the kinase PKR that in turn phosphorylates the elongation factor eIF2α; <b>2</b>) phosphorylation of eIF2α leads to inhibition of protein translation with consequent decrease of Mcl-1 expression; <b>3</b>) reduction of Mcl-1 protein increases unbound Bim, which activates BAX; <b>4</b>) BAX translocates to the mitochondria; <b>5</b>) BAX oligomerizes and induces permeabilization of the mitochondrial outer membrane, allowing the release of cytochrome <i>c</i> to the cytoplasm; <b>6</b>) cytoplasmic cytochrome <i>c</i> forms complexes with Apaf1 and activates the initiator caspase 9; <b>7</b>) finally, caspase 9 cleaves and activates the executioner caspase 3, <b>8</b>) triggering the final steps of beta cell apoptosis; <b>9</b>) further studies are required to clarify additional pathways implicated in virus-induced beta cell apoptosis.…”
-
20162
Fig 1 -
Published 2023“…Mean nucleotide diversity (C) was reduced outside of the core, with a greater reduction for higher selfing: . Relative fitness (D) decreased from core to edge with similar values across outcrossers and selfers: , reflecting a relative loss of fitness as compared to the core of 29.1%, 29.8%, 32.4%, and 31.7% respectively for <i>σ</i> = 0, 0.5, 0.95, and 1.…”
-
20163
-
20164
Table10_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.XLSX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20165
Image4_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.TIF
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20166
Table5_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.DOCX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20167
Image3_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.TIF
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20168
Image2_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.TIF
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20169
Data_Sheet_1_Engineering an in vitro retinothalamic nerve model.pdf
Published 2024“…Using embryonic rat retinas, we developed a model where retinal spheroids innervate thalamic targets through up to 6 mm long microfluidic channels. …”
-
20170
Table6_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.DOCX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20171
Image1_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.TIF
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20172
Table2_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.DOCX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20173
Table9_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.XLSX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20174
Table3_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.DOCX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20175
Table11_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.XLSX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20176
Table1_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.DOCX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20177
Image5_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.TIF
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20178
Table7_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.XLSX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20179
Table8_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.XLSX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”
-
20180
Table4_Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma.DOCX
Published 2021“…Among them, NVP-AUY922 had the lowest IC50 value and might become a potential drug to prolong a patient’s survival. …”